Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
301, E Square,, Subhash Road, Vile Parle (East)
Navi Mumbai; Maharashtra; Map
Postal Code: 400057
Tel: 27630547/ 2663
Fax: 4053
Email: @nglfinechem.com
Website: http://www.nglfinechem.com

Full name: NGL Fine - Chem Ltd.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 1626768
IN-CIN: L24110MH1981PLC025884
ISIN: INE887E01022
Incorporation Date: 1981

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Tablets, Drugs Bulk & Intermediates, Finished Goods,
More

Company Description

NGL Fine-Chem Ltd. engages as a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. The company was incorporated in the year 1981 and has its headquarters based in Navi Mumbai.

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 390.30
Volume 2,037
Turnover 806,703
Index
Market Madras Stock Exchange
Ticker 524774
Market Cap Market Cap 2,411,283
52 Week High 423.15
52 Week Low 218.20
Price to Earnings (P/E) 21.15
Earnings per Share (EPS) 18.45
Dividend Yield
Bookvalue 647,528
Enterprise Value 1,986,464
Quote updated on April 25, 2017
Note: data in INR Thousands.

Export-Import

2013: Imports INR 111,850.26 Thousands
Import connections ('000)
Total(1,807.04)
2013: Exports INR 392,247.17 Thousands
Export connections ('000)
Total(6,337.10)

Key Executives

Chairman & Executive Director
More

Ownership Details

Indian Promoters
66.09%

Key Stats

Select Items to chart them. 2017 Q3C
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets N/A
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Dion Global Solutions Limited, EMIS Company Database.

Financials

Competitors - India

INR | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2016
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest